Vogenx, Inc. (VOGX) stock
VOGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026
$13.48−0.90 (-6.26%)
Close on Nov 17, 2026Market cap $200.25MP/E –Yield –
Vogenx cash
Cash and short-term investments held at the end of each period.
Vogenx's cash was $193.02K at Jun 30, 2026. For fiscal 2025 it was $601.01K, down 37.6% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $601.01K | -37.6% |
| FY2024 | Dec 31, 2024 | $962.92K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $193.02K | – |
| Q4 FY2025 | Dec 31, 2025 | $601.01K | – |
| Q2 FY2025 | Jun 30, 2025 | $390.28K | – |
| Q4 FY2024 | Dec 31, 2024 | $962.92K | – |
See a number that looks wrong?